HY

Hyundai ADM Bio lnc.

Korean CRO offering end-to-end clinical trial services for pharma & bio ventures.

187660 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 종로구 새문안로5길 19, 7층 711호(당주동, 로얄빌딩), 종로구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Hyundai ADM Bio Inc. is a leading Korean Contract Research Organization (CRO) providing comprehensive clinical trial services to pharmaceutical companies and bio ventures. The company offers end-to-end support across all study phases, specializing in clinical operations and medical writing to ensure high-quality, globally standardized trial execution. Leveraging extensive experience and a track record of successful clinical trials, Hyundai ADM Bio positions itself as a key partner in drug development. In addition to its CRO services, the company engages in its own research and development, notably advancing the anti-cancer drug candidate 'Penitrium' in collaboration with its parent company, Hyundai Bioscience.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Hyundai ADM Bio lnc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-03 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 100.9 KB

Automate Your Workflow. Get a real-time feed of all Hyundai ADM Bio lnc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Hyundai ADM Bio lnc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
NANO MRNA Co.,Ltd. Logo
Biotech IP generator developing and licensing mRNA therapeutics using proprietary delivery systems.
Japan 4571
NATURECELL CO.,LTD. Logo
Biotech company developing stem cell therapies, food, beverages, and cosmetics.
South Korea 007390
A marketing support firm using a vast consumer panel for data-driven research and PR campaigns.
Japan 4196
Neovacs Logo
Develops immunotherapy vaccines for autoimmune diseases & invests in BioTech/MedTech companies.
France ALNEV
Mineral explorer of rare earths, niobium, uranium, and copper assets in Australia and Zambia.
Australia N/A
NFL Biosciences Logo
Develops botanical drug candidates to treat smoking and alcohol addictions.
France ALNFL
NGS Group Logo
Nordic staffing & recruitment for healthcare, education, and social services sectors.
Sweden NGS
Nihon M&A Center Holdings Inc. Logo
M&A advisory firm specializing in brokerage and consulting for Japanese SMEs, including cross-border deals.
Japan 2127
Noile-Immune Biotech Inc. Logo
Developing PRIME technology-enhanced CAR-T cell immunotherapies for treating solid tumors.
Japan 4893
NRGene Technologies Ltd. Logo
AI-powered genomic analysis software to accelerate and optimize plant and animal breeding.
Israel NRGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.